Tanguler Tolga insider trades
Tanguler Tolga has filed 25 Form 4s with the SEC that we hold, for Alnylam Pharmaceuticals, INC. (ALNY) (EVP, Chief Commercial Officer) and Lexeo Therapeutics, Inc. (LXEO) (Director). Across all of them we count 0 purchases worth $0 and 129 sales worth $8.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 40 sales ($2.4M). The largest single trade was a sale of 1,959 shares of Alnylam Pharmaceuticals, INC. worth $607.4K, dated 2026-02-13. The first filing on our record is dated 2022-02-03 and the latest 2026-06-29.
Alnylam Pharmaceuticals, INC. (ALNY)
EVP, Chief Commercial Officer · 22 filings · 129 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-07-05 | S, sale reported on Form 4 | 1,754 | $263.1K | 2022-07-07 |
| 2022-08-03 | S, sale reported on Form 4 | 1,754 | $368.3K | 2022-08-05 |
| 2022-08-05 | S, sale reported on Form 4 | 149 | $32.0K | 2022-08-05 |
| 2022-08-05 | S, sale reported on Form 4 | 398 | $86.1K | 2022-08-05 |
| 2022-08-05 | S, sale reported on Form 4 | 440 | $95.7K | 2022-08-05 |
| 2022-08-05 | S, sale reported on Form 4 | 541 | $118.3K | 2022-08-05 |
| 2022-08-05 | S, sale reported on Form 4 | 99 | $21.7K | 2022-08-05 |
| 2022-08-05 | S, sale reported on Form 4 | 105 | $23.2K | 2022-08-05 |
| 2022-08-05 | S, sale reported on Form 4 | 5 | $1.1K | 2022-08-05 |
| 2022-08-05 | S, sale reported on Form 4 | 104 | $23.4K | 2022-08-05 |
| 2023-02-02 | S, sale reported on Form 4 | 4 | $910 | 2023-02-03 |
| 2023-02-02 | S, sale reported on Form 4 | 73 | $16.3K | 2023-02-03 |
| 2023-02-02 | S, sale reported on Form 4 | 963 | $217.4K | 2023-02-03 |
| 2023-02-02 | S, sale reported on Form 4 | 561 | $127.1K | 2023-02-03 |
| 2023-02-03 | S, sale reported on Form 4 | 953 | $222.3K | 2023-02-03 |
| 2023-02-03 | S, sale reported on Form 4 | 1,293 | $300.7K | 2023-02-03 |
| 2023-02-03 | S, sale reported on Form 4 | 128 | $29.1K | 2023-02-03 |
| 2023-02-03 | S, sale reported on Form 4 | 185 | $42.6K | 2023-02-03 |
| 2023-02-03 | S, sale reported on Form 4 | 865 | $200.1K | 2023-02-03 |
| 2023-04-27 | S, sale reported on Form 4 | 103 | $20.3K | 2023-04-28 |
| 2023-04-27 | S, sale reported on Form 4 | 64 | $12.5K | 2023-04-28 |
| 2023-04-27 | S, sale reported on Form 4 | 562 | $109.0K | 2023-04-28 |
| 2023-04-27 | S, sale reported on Form 4 | 625 | $121.8K | 2023-04-28 |
| 2023-04-27 | S, sale reported on Form 4 | 122 | $23.6K | 2023-04-28 |
| 2024-02-16 | S, sale reported on Form 4 | 519 | $76.9K | 2024-02-20 |
| 2024-02-16 | S, sale reported on Form 4 | 369 | $54.4K | 2024-02-20 |
| 2024-02-16 | S, sale reported on Form 4 | 121 | $18.0K | 2024-02-20 |
| 2024-02-28 | S, sale reported on Form 4 | 170 | $26.4K | 2024-02-29 |
| 2024-02-28 | S, sale reported on Form 4 | 100 | $15.6K | 2024-02-29 |
| 2024-02-28 | S, sale reported on Form 4 | 1 | $158 | 2024-02-29 |
| 2024-02-28 | S, sale reported on Form 4 | 216 | $33.4K | 2024-02-29 |
| 2024-02-28 | S, sale reported on Form 4 | 14 | $2.2K | 2024-02-29 |
| 2024-06-25 | S, sale reported on Form 4 | 34 | $7.7K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 129 | $29.5K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 266 | $60.9K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 304 | $69.9K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 99 | $22.9K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 216 | $50.2K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 115 | $26.9K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 185 | $43.4K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 167 | $39.3K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 59 | $13.1K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 13 | $2.9K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 18 | $4.1K | 2024-06-26 |
| 2024-11-26 | S, sale reported on Form 4 | 826 | $207.7K | 2024-11-27 |
| 2024-11-26 | S, sale reported on Form 4 | 318 | $79.7K | 2024-11-27 |
| 2024-11-26 | S, sale reported on Form 4 | 215 | $53.7K | 2024-11-27 |
| 2024-11-26 | S, sale reported on Form 4 | 26 | $6.4K | 2024-11-27 |
| 2024-11-26 | S, sale reported on Form 4 | 84 | $21.2K | 2024-11-27 |
| 2025-02-28 | S, sale reported on Form 4 | 50 | $12.0K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 82 | $19.8K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 192 | $46.5K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 78 | $19.0K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 38 | $9.3K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 23 | $5.5K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 22 | $5.2K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 28 | $6.6K | 2025-03-03 |
| 2025-03-03 | S, sale reported on Form 4 | 96 | $23.5K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 70 | $17.2K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 29 | $7.1K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 142 | $34.6K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 3 | $742 | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 131 | $31.8K | 2025-03-05 |
| 2025-08-18 | S, sale reported on Form 4 | 39 | $17.5K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 90 | $40.5K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 39 | $17.6K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 103 | $46.6K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 329 | $149.0K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 543 | $246.5K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 241 | $109.6K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 12 | $5.5K | 2025-08-19 |
| 2025-08-29 | S, sale reported on Form 4 | 681 | $306.1K | 2025-09-02 |
| 2025-08-29 | S, sale reported on Form 4 | 1,289 | $577.5K | 2025-09-02 |
| 2025-08-29 | S, sale reported on Form 4 | 899 | $401.8K | 2025-09-02 |
| 2025-08-29 | S, sale reported on Form 4 | 195 | $86.9K | 2025-09-02 |
| 2025-08-29 | S, sale reported on Form 4 | 266 | $120.1K | 2025-09-02 |
| 2025-08-29 | S, sale reported on Form 4 | 144 | $65.2K | 2025-09-02 |
| 2025-10-02 | S, sale reported on Form 4 | 117 | $53.2K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 157 | $71.2K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 319 | $144.4K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 159 | $71.8K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 260 | $117.2K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 119 | $53.5K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 86 | $38.6K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 70 | $32.0K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 35 | $16.0K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 27 | $12.1K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 55 | $24.6K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 1 | $458 | 2025-10-03 |
| 2026-01-12 | S, sale reported on Form 4 | 15 | $5.7K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 42 | $14.9K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 41 | $14.6K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 96 | $34.3K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 123 | $44.1K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 85 | $30.5K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 155 | $55.8K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 98 | $35.4K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 73 | $26.5K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 47 | $17.1K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 199 | $72.6K | 2026-01-14 |
Newest 100 of 129
Lexeo Therapeutics, Inc. (LXEO)
Director · 3 filings · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1849458) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms